Omecamtiv Mecarbil (OM)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionNCT06736574CytokineticsPhase 3Recruiting2027-09Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.